Authors
Loading...
In vitro study reveals that wortmannin selectively blocks Fc epsilon R1 signaling and PI 3-kinase activities in mast cells, highlighting distinct pathways in allergic activation.
Barker et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: